Mustafa Balcioglu
Overview
Explore the profile of Mustafa Balcioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
986
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Correa A, Kalashnikova E, Wu H, Winters R, Balcioglu M, Sudhaman S, et al.
Oncologist
. 2024 Jul;
29(10):887-893.
PMID: 39013784
Background: Despite complete resection, 20%-50% of patients with localized renal cell carcinoma (RCC) experience recurrence within 5 years. Accurate assessment of prognosis in high-risk patients would aid in improving outcomes....
2.
Gruber J, Afghahi A, Timms K, DeWees A, Gross W, Aushev V, et al.
Nat Cancer
. 2022 Oct;
3(10):1181-1191.
PMID: 36253484
Talazoparib, a PARP inhibitor, is active in germline BRCA1 and BRCA2 (gBRCA1/2)-mutant advanced breast cancer, but its activity beyond gBRCA1/2 is poorly understood. We conducted Talazoparib Beyond BRCA ( NCT02401347...
3.
Cailleux F, Agostinetto E, Lambertini M, Rothe F, Wu H, Balcioglu M, et al.
JCO Precis Oncol
. 2022 Sep;
6:e2200148.
PMID: 36170624
Purpose: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy in patients with early-stage breast cancer may allow for early detection of relapse. In this study, we analyzed ctDNA using...
4.
Dhakal B, Sharma S, Balcioglu M, Shchegrova S, Malhotra M, Zimmermann B, et al.
Front Oncol
. 2022 Feb;
12:786451.
PMID: 35186734
Background: Despite treatment with high-dose chemotherapy followed by autologous stem cell transplantation (AHCT), patients with multiple myeloma (MM) invariably relapse. Molecular residual disease (MRD)-negativity post-AHCT has emerged as an important...
5.
Balcioglu M, Buyukbekar B, Yavuz M, Yigit M
ACS Biomater Sci Eng
. 2021 Jan;
1(1):27-36.
PMID: 33435080
In this work, we have developed a general methodology for constructing an activatable biosensor utilizing a thermoresponsive polymer and two-dimensional nanosheet. We have demonstrated the detection of four different types...
6.
Balcioglu M, Rana M, Yigit M
J Mater Chem B
. 2020 Apr;
1(45):6187-6193.
PMID: 32261691
We report the facile and non-covalent construction of a graphene oxide-based functional hybrid material with gold and fluorescently labeled superparamagnetic iron oxide nanoparticles [GO-MN-AuNP]. The obtained [GO-MN-AuNP] hybrid exhibits the...
7.
Reinert T, Vesterman Henriksen T, Christensen E, Sharma S, Salari R, Sethi H, et al.
JAMA Oncol
. 2019 May;
5(8):1124-1131.
PMID: 31070691
Importance: Novel sensitive methods for detection and monitoring of residual disease can improve postoperative risk stratification with implications for patient selection for adjuvant chemotherapy (ACT), ACT duration, intensity of radiologic...
8.
Christensen E, Birkenkamp-Demtroder K, Sethi H, Shchegrova S, Salari R, Nordentoft I, et al.
J Clin Oncol
. 2019 May;
37(18):1547-1557.
PMID: 31059311
Purpose: Novel sensitive methods for early detection of relapse and for monitoring therapeutic efficacy may have a huge impact on risk stratification, treatment, and ultimately outcome for patients with bladder...
9.
Coombes R, Page K, Salari R, Hastings R, Armstrong A, Ahmed S, et al.
Clin Cancer Res
. 2019 Apr;
25(14):4255-4263.
PMID: 30992300
Purpose: Up to 30% of patients with breast cancer relapse after primary treatment. There are no sensitive and reliable tests to monitor these patients and detect distant metastases before overt...
10.
Hizir M, Robertson N, Balcioglu M, Alp E, Rana M, Yigit M
Chem Sci
. 2017 Oct;
8(8):5735-5745.
PMID: 28989614
A typical lock-and-key sensing strategy, relying only on the most dominant interactions between the probe and target, could be too limiting. In reality, the information received upon sensing is much...